Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
5.35
-0.01 (-0.19%)
At close: Sep 5, 2025, 4:00 PM
5.39
+0.04 (0.75%)
After-hours: Sep 5, 2025, 4:10 PM EDT

Eupraxia Pharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts that cover Eupraxia Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $11.5, which forecasts a 114.95% increase in the stock price over the next year. The lowest target is $11 and the highest is $12.

Price Target: $11.5 (+114.95%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$11$11.5$12$12
Change+105.61%+114.95%+124.30%+124.30%

Analyst Ratings

The average analyst rating for Eupraxia Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25
Strong Buy11111
Buy00111
Hold00000
Sell00000
Strong Sell00000
Total11222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong BuyReiterates$12+124.30%Aug 20, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$11
BuyInitiates$11+105.61%Jul 24, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$12
Strong BuyInitiates$12+124.30%Jun 26, 2025
Rodman & Renshaw
Rodman & Renshaw
Strong Buy
Initiates
$9
Strong BuyInitiates$9+68.22%Nov 14, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.05
from -0.76
EPS Next Year
-1.10
from -1.05
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-0.51-1.53-0.96-1.17-0.76-1.05-1.10
EPS Growth
-------
Forward PE
-------
No. Analysts
-----55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-0.97-0.85
Avg-1.05-1.10
Low-1.12-1.19

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.